Rendi Aji Prihaningtyas

Rendi Aji Prihaningtyas

Auto-generated profile, based on publicly available information

Rendi Aji Prihaningtyas

Department of Child Health, Dr. Soetomo General Academic Hospital, Surabaya, Indonesia. Department of Child Health, Faculty of Medicine – Universitas Airlangga, Surabaya, Indonesia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2019 in Pan African Medical Journal
Verified
Journal Article
Open access
NWNur Aisiyah Widjaja
Nur Aisiyah Widjaja
RIRoedi Irawan
Roedi Irawan
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
MAMeity Ardiana
Meity Ardiana
MHMeta Herdiana Hanindita
Meta Herdiana Hanindita
Obesity is a global health problem with growing prevalence in developing countries. Obesity causes chronic inflammation due to imbalances between pro- and anti-inflammatory cytokines. This causes metabolic complications such as dyslipidemia, hypertension, and cardiovascular disorder. Carotid intima–media thickness (CIMT) is a predictor of atherosclerosis which could be measured easily and non-invasively. Early detection of cardiovascular diseases in obese adolescents at risk is hoped to improve outcomes. This is a cross-sectional study on obese adolescents aged 13-16 year old at Pediatric Clinic of Dr. Soetomo General Hospital. Obesity is defined as Body mass index higher than 95th percentiles according to CDC (2000). Dyslipidemia is diagnosed when either an increase in cholesterol, LDL, triglyceride or a decrease in HDL level is found, as recommended by NCPE and American Academy of Pediatrics. Hypertension is defined as an increase of blood pressure > P95 according to age and gender. The differences of CIMT based on dyslipidemia, hypertension, and gender were analyzed with Wilcoxon Mann Whitney with significant p value (p < 0,005). This study included 59 obese adolescents, consisting of 32 (54.2%) male adolescents and 35 (59.3%) female adolescents. Dyslipidemia was found on 38 (64.4%) adolescents and hypertension was found on 35 (59.3%) adolescents. No difference of CIMT was found between obese adolescents with and without dyslipidemia and with and without hypertension based on gender (p > 0.05). No difference of CIMT based on gender between adolescents aged below 18. The high number of dyslipidemia and hypertension in obese adolescents need an early detection of cardiovascular complication.

4 June 2021 in Sri Lanka Journal of Child Health
Verified
Journal Article
Open access
PDF file
IUI Ketut Alit Utamayasa
I Ketut Alit Utamayasa
AIAjeng Indriastari
Ajeng Indriastari
THTaufiq Hidayat
Taufiq Hidayat
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
MRMahrus Rahman
Mahrus Rahman
TOTeddy Ontoseno
Teddy Ontoseno
Introduction: In developing countries, rheumatic heart disease (RHD) affects 19 per 100.000 children. There are few systematically collected data on children with RHD in developing countries.Objective: To describe the clinical profile of children with RHD in Indonesia.Method: A cross-sectional study was conducted on children diagnosed with RHD who came to the paediatric cardiology outpatient clinic of Dr. Soetomo General Hospital from June 2014 to June 2015. Demographic data and clinical characteristics of RHD were collected.Results: Fifty children were diagnosed with RHD during the study period. The median age was 10.9 years. Female to male ratio was 1.2:1. At the time of initial diagnosis, 28% children had acute rheumatic fever (ARF) and 72% had RHD. Major clinical manifestations were carditis (86%), polyarthritis migrans (10%) and chorea (2%). Minor clinical manifestations were fever (36%), arthralgia (8%). positive C-reactive protein (60%), elevated erythrocyte sedimentation rate (68%) and prolonged PR interval on electrocardiogram (2%). Raised anti-streptolysin O titre was present in 44%. The common valve lesions were MR (86%), tricuspid regurgitation (42%) and aortic regurgitation (38%).Conclusions: Carditis was the commonest major clinical manifestation in past ARF and MR the commonest valve lesion in children with RHD.Sri Lanka Journal of Child Health, 2021; 50(2): 200-202

4 March 2021 in Sri Lanka Journal of Child Health
Verified
Journal Article
Open access
PDF file
BSBagus Setyoboedi
Bagus Setyoboedi
RWReny Widayanti
Reny Widayanti
SASjamsul Arief
Sjamsul Arief
DPDwiyanti Puspitasari
Dwiyanti Puspitasari
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
Introduction: The incidence of cholestasis in infancy is associated with congenital or viral infection. Commonest cause is Cytomegalovirus (CMV) infection. In Indonesia, diagnosis of cholestasis due to CMV infection is still not optimal because the support of virological examination is still limited, so serological examination is an option.Objective: Analysing the agreement of CMV IgG or IgM serological examination and CMV polymerase chain reaction (PCR) examination of liver tissue in infants with cholestasisMethod: This is an analytic observational research using cross sectional design. Samples were infants with cholestasis, 1-12 months of age, in the Department of Child Health, Dr. Soetomo General Hospital, who met the inclusion criteria. Samples were taken from December 2017- May 2018. Liver biopsy was done in Department of Child Health, Dr. Soetomo Hospital. CMV PCR examination of liver tissue was carried out in the Tropical Disease Laboratory at Airlangga University. Data were analysed by calculating the kappa coefficient CMV IgG or IgM serology examination and CMV PCR examination of liver tissue.Results: There were 30 infants with cholestasis, consisting of 16 (53%) boys and 14 (47%) girls. Positive CMV IgG was found in 28 subjects and CMV IgM was found in 15 subjects. CMV PCR was positive in 20 (67%) subjects. The most common age range with positive CMV IgG and IgM as well as CMV PCR was 1-3 months. Agreement of CMV IgG compared to CMV PCR of liver tissue showed weak result with kappa value of 0.25. The agreement of CMV IgM compared to CMV PCR of liver tissue was not found with kappa value 0.00.Conclusions: In infants with cholestasis, there is no agreement for CMV serological examination with CMV PCR of liver tissue. CMV serologic examination cannot replace CMV PCR of liver tissue to determine the presence of CMV virus in infant with cholestasis.Sri Lanka Journal of Child Health, 2021; 50(1): 43-48

14 April 2023 in Surabaya Medical Journal
Verified
Journal Article
Open access
PDF file
NWNur Aisiyah Widjaja
Nur Aisiyah Widjaja
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
MHMeta Herdiana Hanindita
Meta Herdiana Hanindita
RHRetno Handajani
Retno Handajani
IUI Dewa Gede Ugrasena
I Dewa Gede Ugrasena
Background: Homeostasis model assessment (HOMA) is a method used to measure insulin resistance (IR). Adiponectin is involved in the development of atherosclerosis. Objectives: This study aimed to assess metabolic syndrome (MetS) prevalence in adolescents with obesity; correlate HOMA-IR and IR incidence with MetS biochemical parameters and MetS components; as well as correlate adiponectin levels and hypoadiponectinemia incidence with MetS biochemical parameters and MetS components. Methods: This study was conducted at the Outpatient Installation Unit of Nutrition and Metabolic Diseases, Child Health Department, Dr. Soetomo General District Hospital, Surabaya, Indonesia with a cross-sectional study design. It lasted for nine months and focused on obese adolescents aged 13-18 years. Anthropometric measurements and blood biochemistry analyses were done. HOMA-IR was calculated using the formula [glucose (mg/dL) x Insulin (µu/L)]/405. Results: A total of 216 obese adolescents took part in the study. MetS was found in 81 subjects (37.96%). There was weak correlation between HOMA-IR ​​with anthropometric measurements, lipid profiles, fasting blood glucose, and serum adiponectin levels (p<0.05). IR was found to increase the risk of MetS development by 1.661-times, dyslipidemia by 1.845-times, and abdominal obesity by 3.077-times. IR increased the risk of MetS incidence with more than three IDF criteria by 9.368-times. There was a correlation between adiponectin levels with the HDL-c. Hypoadiponectinemia was correlated with the incidence of MetS, abdominal obesity, and hypertriglyceridemia. It also increased the risk of developing MetS by 2.220-times. There was a positive relationship between IR HOMA value ​​and the anthropometric parameters of obesity and MetS parameters. Conclusions: IR was found to be associated with dyslipidemia, abdominal obesity, and MetS incidence with more than three IDF criteria. There was a relationship between hypoadiponectinemia and waist circumference, hip circumference, HDL-c, and triglycerides. Insulin resistance and hypoadiponectinemia were associated with Mets and hypertriglyceridemia incidence.

5 June 2024 in Sri Lanka Journal of Child Health
Verified
Journal Article
Open access
PDF file
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
BSBagus Setyoboedi
Bagus Setyoboedi
SASjamsul Arief
Sjamsul Arief
Introduction: Biliary atresia is a hepatobiliary disease which frequently results in portal hypertension.Objectives: To analyse the risk factors for portal hypertension in children with biliary atresia.Method: A case-controlled study was performed on 96 children with biliary atresia. Subjects were enrolled based on the inclusion and exclusion criteria. Medical history, physical examination results, imaging data, and laboratory examination results were collected prospectively. Patients were divided into two groups based on the signs of portal hypertension clinically during the follow-up period. Risk factors for portal hypertension were analysed using SPSS. Univariate analysis was used first to identify possible risk factors. A multivariate analysis was performed using logistic regression with p significant <0.05.Results: The median age was 18.21 (3.14-128.86) weeks in the portal hypertension group and 9.07 (1.00-50.57) weeks in the non-portal hypertension group. Age, duration of illness, birth weight, gestational age, and laboratory examination [Haemoglobin (Hb), white blood cell (WBC) count, albumin, direct bilirubin, total bilirubin, prothrombin time (PT), gamma-glutamyl transferase (GGT), aspartate transaminase (AST), and AST: alanine transaminase (ALT) ratio] were significantly different in the 2 groups (p<0.05). For every one-week increase in the subject's age, the risk of portal hypertension increased by 1.127. For every one unit increase in Hb, PT, GGT, and the AST:ALT ratio, the risk of having portal hypertension was 0.746, 1.125, 1.00, and 2.862 in children with biliary atresia (p<0,05).Conclusions: The risk factors for portal hypertension in children with biliary atresia were age, Hb, PT, GGT levels, and the AST:ALT ratio.

13 March 2026 in INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY
Verified
Journal Article
Open access
PDF file
NHNur Hanifah
Nur Hanifah
BSBagus Setyoboedi
Bagus Setyoboedi
CWCitrawati Wungu
Citrawati Wungu
RPRendi Aji Prihaningtyas
Rendi Aji Prihaningtyas
Bile excretion disorders, such as cholestasis could affect people of all ages, including newborns. Although it has been regularly used to treat cholestasis, the use of ursodeoxycholic acid in pediatric patients remains a topic of debate. This study aims to assess the impact of ursodeoxycholic acid treatment on liver biomarkers in pediatric cholestasis across distinct age groups (under 3 months and 3-36 months). This was an observational analytic study using the retrospective cohort method in children with cholestasis who had received ursodeoxycholic acid therapy for 2 weeks. Secondary data including routine liver function tests; aspartate aminotransferase (AST), alanine aminotransferase (ALT), total bilirubin, and direct bilirubin were taken from medical records of the outpatient clinic in the Department of Child Health, Dr. Soetomo General Hospital, Surabaya, Indonesia, from January 2020 to December 2023. Subjects who met the inclusion criteria were divided into 2 groups based on age. The first group contains subjects with an age range of 1-3 months, while the other group contains subjects older than 3 months to 36 months. A total of 104 subjects were dominated by the male gender (56.07%). The results of the comparative test showed that the levels of AST, ALT, total bilirubin and direct bilirubin were decreased in both groups, except for ALT levels in children aged <3 months. Younger children had a significant increase in ALT levels after administration of ursodeoxycholic acid (281.8±165.2 vs 224.1±167.2, p =0.019). This was attributed to drug interactions due to the use of multiple medications that could not be controlled. Significant decreases occurred in the values of AST, total bilirubin, direct bilirubin (group 1) and AST (group 2) with sequential values were 179.2±139.2 vs 294.5±229.7, p =0.033; 10.8±4.5 vs 6.6±5.3 p =0.019; 7.3±3.6 vs 4.7±3.9 p <0.001 and 229.8±175.7 vs 229.6±210.9 p <0.001. While the difference in the values of the four parameters between the two groups was found in AST and total bilirubin marker. Ursodeoxycholic acid is effective in improving liver function biomarkers in pediatric cholestasis. Therapeutic response to ursodeoxycholic acid administration is more commonly found in younger age.